Increasing the proliferative capacity of cells using telomerase reverse transcriptase
US7585622B1 · kind B1 · utility
11Cited by
62References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 2, 1999 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Nov 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.